![Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7102e1_PfizerMIS-C_IMAGE_07Jan22_SOCIAL_1200x675-medium.jpg?_=63592)
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
![Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care - ScienceDirect Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109718344139-fx1.jpg)
Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care - ScienceDirect
![Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke](https://www.ahajournals.org/cms/asset/8807f3f5-0f0d-403d-948a-a8e8aaff4bcc/strokeaha.120.033033.fig03.jpg)
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
![Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens: Molecular Therapy Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens: Molecular Therapy](https://www.cell.com/cms/asset/64dc8b8e-4cf1-436b-9ee0-2327bc97c361/fx1.jpg)
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens: Molecular Therapy
![Enhancers in disease: molecular basis and emerging treatment strategies: Trends in Molecular Medicine Enhancers in disease: molecular basis and emerging treatment strategies: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/702cfb9a-6c01-4c63-8412-c2e570470ffe/gr1_lrg.jpg)
Enhancers in disease: molecular basis and emerging treatment strategies: Trends in Molecular Medicine
![Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/928d891d-cb46-4fa9-9f7d-7807c726c8cf/gr1.jpg)
Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences
![Astrazeneca R&D - Improving Drug Development Productivity With Better Predictivity - Drug Discovery World (DDW) Astrazeneca R&D - Improving Drug Development Productivity With Better Predictivity - Drug Discovery World (DDW)](https://www.ddw-online.com/wp-content/uploads/2020/08/12-improving-productivity-1200x847.jpg)
Astrazeneca R&D - Improving Drug Development Productivity With Better Predictivity - Drug Discovery World (DDW)
![JPM | Free Full-Text | Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe JPM | Free Full-Text | Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe](https://www.mdpi.com/jpm/jpm-12-00072/article_deploy/html/images/jpm-12-00072-g001.png)
JPM | Free Full-Text | Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
![Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera - ScienceDirect Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867421002269-fx1.jpg)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera - ScienceDirect
![The impact of the COVID-19 pandemic on cardiovascular disease prevention and management | Nature Medicine The impact of the COVID-19 pandemic on cardiovascular disease prevention and management | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-02158-7/MediaObjects/41591_2022_2158_Fig1_HTML.png)
The impact of the COVID-19 pandemic on cardiovascular disease prevention and management | Nature Medicine
![Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca - ScienceDirect Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517321011935-ga1.jpg)